Highly sensitive profiling of CD44+/CD24- breast cancer stem cells by combining global mRNA amplification and next

Olaf Hardt1, Stefan Wild, Ilka Oerlecke

  • 1Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.

Cancer Letters
|July 10, 2012
PubMed

Related Concept Videos